The first biosimilar version of Pfizer/Amgen’s multi-billion-dollar anti-inflammatory Enbrel (etancerpt) has now been launched in the UK, offering access to a cheaper alternative that could drive down ...

Biogen (BIIB) today announced further progress as part of its commitment to biosimilars. Samsung Bioepis, the joint venture between Samsung Biologics and Biogen, has received a positive opinion from ...

ZUG, Switzerland--(BUSINESS WIRE)--Real world evidence from investigator-initiated studies supported by Biogen (NASDAQ: BIIB), demonstrating sustained efficacy and safety, and high acceptance and ...

Shares of Biogen Inc (NASDAQ: BIIB) were trading higher by 2 percent at $279.00 early Tuesday morning after the company announced that the European Union has granted marketing authorization for its ...

ZUG, Switzerland--(BUSINESS WIRE)--The joint venture between Biogen (NASDAQ:BIIB) and Samsung BioLogics, Samsung Bioepis, has been granted European Commission (EC) approval for BENEPALI® , an ...

LIVERPOOL -- Switching from etanercept (Enbrel) to its biosimilar Benepali was successfully implemented in a single-center study of patients with rheumatoid arthritis, investigators reported here.

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced real-world data of BENEPALI™ in patients with moderate to severe psoriasis from the British Association of Dermatologists ...

Ÿ In just under four years, Samsung Bioepis develops, tests and receives regulatory approval for Benepali®, the first etanercept biosimilar in the European Union Ÿ The European Commission approval ...

The joint venture between Biogen (NASDAQ: BIIB) and Samsung BioLogics, Samsung Bioepis, has been granted European Commission (EC) approval for BENEPALI ®, an etanercept biosimilar referencing Enbrel ® ...

Egypt will slow down large state projects that involve high fuel and diesel consumption for at least two months, while fuel ‌allocations for all government vehicles will be cut by 30%, Prime Minister ...

BENEPALI, as the first etanercept biosimilar referencing Enbrel approved in the EU, can help expand access to treatment options for people affected by chronic inflammatory conditions.” The EC approval ...

Real-world data from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) shows that BENEPALI™ is effective in patients with psoriasis INCHEON, Korea — Samsung ...